Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT05947175

Vertebral Bone Marrow Clot for Spinal Surgery

Led by Istituto Ortopedico Rizzoli · Updated on 2025-03-26

96

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Spinal fusion (SF) is a common orthopedic procedure to treat spinal diseases. Apart from fixation systems, the procedure requires bone grafting to further improve SF. Cell-based therapies as vertebral bone marrow aspirate (vBMA) with bone allograft were developed as alternative to bone autograft in SF. However, vBMA use is limited by the lack of a standardized procedure, of a structural texture and by the possibility of diffusion away from the implant site. Recently, the potential use of a new formulation of vBMA, named vBMA clot, has been described. The project aims at evaluating the clinical evidence and the biological features of vBMA clot associated to bone allograft for SF surgery, considering age and gender related differences. A randomized controlled trial will prove the efficacy of the treatment and advanced preclinical studies will improve the knowledge on vBMA clot regenerative and anti-inflammatory properties, exploring for the first time its antibacterial characteristics.

CONDITIONS

Official Title

Vertebral Bone Marrow Clot for Spinal Surgery

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with degenerative spinal disorders based on radiological diagnosis
  • Scheduled for posterior spinal stabilization involving 5 or fewer spinal levels
  • Aged between 18 and 80 years at the time of surgery
Not Eligible

You will not qualify if you...

  • Presence of HIV infection
  • Presence of hepatitis B virus (HBV) infection
  • Presence of hepatitis C virus (HCV) infection
  • Coagulation disorders
  • Pregnant or breast-feeding women
  • Current cancer diagnosis
  • Active infections
  • Previous spinal surgery
  • History of radio-chemotherapy
  • Diagnosis of myeloproliferative disease
  • Use of chronic steroid medication, thyroxin, or immunosuppressive therapy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Istituto Ortopedico Rizzoli

Bologna, BO, Italy, 40136

Actively Recruiting

Loading map...

Research Team

F

Francesca Salamanna, PhD

CONTACT

M

Maria Sartori, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Vertebral Bone Marrow Clot for Spinal Surgery | DecenTrialz